These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5413517)

  • 1. [Extrahepatic uptake of ammonia in patients with hepatic encephalopathy].
    Gucalová OY; Niederland TR
    Cas Lek Cesk; 1970 Feb; 109(6):124-8. PubMed ID: 5413517
    [No Abstract]   [Full Text] [Related]  

  • 2. Some concepts on ammonia, porta-systemic shunts, and encephalopathy.
    Gips CH; Hindfelt B; Holmin T; Kardel T
    Scand J Gastroenterol; 1973; 8(5):385-8. PubMed ID: 4584758
    [No Abstract]   [Full Text] [Related]  

  • 3. Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.
    Zeegen R; Drinkwater JE; Fenton JC; Vince A; Dawson AM
    Q J Med; 1970 Apr; 39(154):245-63. PubMed ID: 5449591
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hydroxyproline excretion in children with chronic liver diseases].
    Zhivitsa LV; Safonova ES
    Vopr Okhr Materin Det; 1976 May; 21(5):64-7. PubMed ID: 1027285
    [No Abstract]   [Full Text] [Related]  

  • 5. Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS.
    Olde Damink SW; Jalan R; Redhead DN; Hayes PC; Deutz NE; Soeters PB
    Hepatology; 2002 Nov; 36(5):1163-71. PubMed ID: 12395326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].
    Germain L; Frexinos J; Louis A; Ribet A
    Arch Fr Mal App Dig; 1973 Jun; 62(4):293-302. PubMed ID: 4594755
    [No Abstract]   [Full Text] [Related]  

  • 8. [Protein metabolism and detoxification in liver insufficiency].
    Müting D
    Verh Dtsch Ges Inn Med; 1969; 75():44-51. PubMed ID: 5400176
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of arginine malate in experimental and clinical hyperammonemia].
    Szãm I; Szentner J; Hegedüs-Wein I; Vass A
    Int J Clin Pharmacol; 1972 Aug; 6(3):260-5. PubMed ID: 4648469
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurologic changes in liver disease.
    Victor M
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():1-12. PubMed ID: 4438813
    [No Abstract]   [Full Text] [Related]  

  • 11. Brain metabolism of 13N-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography.
    Keiding S; Sørensen M; Bender D; Munk OL; Ott P; Vilstrup H
    Hepatology; 2006 Jan; 43(1):42-50. PubMed ID: 16374868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance in liver disease and portal hypertension.
    Petrides AS; Strohmeyer G; DeFronzo RA
    Prog Liver Dis; 1992; 10():311-28. PubMed ID: 1296234
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of lactulose in the treatment of chronic porto-cave encephalopathy (20 cases)].
    Geffroy Y; Segrestin M; Geffroy PY
    Therapeutique; 1970 Nov; 46(9):897-901. PubMed ID: 5486138
    [No Abstract]   [Full Text] [Related]  

  • 15. Severity of organ failure is an independent predictor of intracranial hypertension in acute liver failure.
    Kitzberger R; Funk GC; Holzinger U; Miehsler W; Kramer L; Kaider A; Ferenci P; Madl C
    Clin Gastroenterol Hepatol; 2009 Sep; 7(9):1000-6. PubMed ID: 19465152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
    Mínguez B; García-Pagán JC; Bosch J; Turnes J; Alonso J; Rovira A; Córdoba J
    Hepatology; 2006 Apr; 43(4):707-14. PubMed ID: 16557541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extrahepatic extraction of ammonia in patients with chronic liver disorders].
    Niederland TR; Gucalová OY
    Bratisl Lek Listy; 1970 Apr; 53(4):388-93. PubMed ID: 5447152
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hepatic component in alcoholic encephalopathy.
    Banciu T; Weidenfeld H; Wilham V; Berinde L; David P; Sgăvirdea C; Ocica I
    Med Interne; 1982; 20(1):67-71. PubMed ID: 7123107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between tumor necrosis factor-alpha and ammonia in patients with hepatic encephalopathy due to chronic liver failure.
    Odeh M; Sabo E; Srugo I; Oliven A
    Ann Med; 2005; 37(8):603-12. PubMed ID: 16338762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.